EGFR and neoplasm: The results showed that patients with a high proportion of HIP1R+, CDKN2A+, and IDHR132H+ tumor cells had a significantly better prognosis than those with a low proportion of positive tumor cells (Figure 2C), while a high proportion of EGFR+ tumor cells was associated with a poor prognosis.